Iovance Biotherapeutics (IOVA) Other financing activities (2015 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Other financing activities of -$4.2 million for Q1 2026, up 25.96% year-over-year from -$3.3 million in Q1 2025, and down 800.65% quarter-over-quarter from -$464000.0 in Q3 2025.
Iovance Biotherapeutics (IOVA) Other financing activities (2015 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other financing activities for 12 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 25.96% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$5.1 million (up 81.11% YoY), while the FY2025 annual figure was $15000.0, up 100.12% from the prior year.
- Other financing activities fell to -$4.2 million in Q1 2026 per IOVA's latest filing, from -$464000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $4.3 million in Q3 2022 and bottomed at -$14.3 million in Q4 2024.
- Historically, Other financing activities has averaged -$2.8 million across 5 years, with a median of -$2.6 million in 2022.
- Annual changes were most pronounced in 2022 — Other financing activities soared 146.54% — and 2024, when it sank 1556.2%.
- Iovance Biotherapeutics' Other financing activities stood at -$4.3 million in 2022, then soared by 33.58% to -$2.8 million in 2023, then tumbled by 402.63% to -$14.3 million in 2024, then soared by 96.76% to -$464000.0 in 2025, then sank by 800.65% to -$4.2 million in 2026.
- Business Quant data shows IOVA's Other financing activities at -$4.2 million in Q1 2026, -$464000.0 in Q3 2025, and -$504000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Jun 30, 2026 | -1.17 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Sep 30, 2025 | -464,000.00 |
| Sep 30, 2025 | -464,000.00 |
| Jun 30, 2025 | -504,000.00 |
| Jun 30, 2025 | -504,000.00 |
| Mar 31, 2025 | -5.64 Mn |
| Mar 31, 2025 | -5.64 Mn |
| Dec 31, 2024 | -14.33 Mn |
| Dec 31, 2024 | -14.33 Mn |
| Sep 30, 2024 | -6.28 Mn |
| Sep 30, 2024 | -6.28 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -4.70 Mn |
| Mar 31, 2024 | -4.70 Mn |
| Dec 31, 2023 | -2.85 Mn |
| Dec 31, 2023 | -2.85 Mn |